Cleavage factor 25 deregulation contributes to pulmonary fibrosis through alternative polyadenylation

Tingting Weng, Junsuk Ko, Chioniso P Masamha, Zheng Xia, Yu Xiang, Ning-yuan Chen, Jose G Molina, Scott Collum, Tinne C Mertens, Fayong Luo, Kemly Philip, Jonathan Davies, Jingjing Huang, Cory Wilson, Rajarajan A Thandavarayan, Brian A Bruckner, Soma SK Jyothula, Kelly A Volcik, Lei Li, Leng Han, Wei Li, Shervin Assassi, Harry Karmouty-Quintana, Eric J Wagner, Michael R Blackburn
2019-05-01
Abstract:Idiopathic pulmonary fibrosis (IPF) is a deadly disease with a poor prognosis and few treatment options. Pathological remodeling of the extracellular matrix (ECM) is a key factor that drives the disease pathogenesis, although the underlying mechanisms remain unknown. Alternative polyadenylation (APA) has recently been shown to play a major role in cellular responses to stress by driving the expression of fibrotic factors through the alteration of miRNA sensitivity, but a connection to IPF has not been established. Here, we demonstrated that CFIm25, a global regulator of APA, was downregulated in the lungs of patients with IPF and mice with pulmonary fibrosis, with its expression selectively reduced in α–smooth muscle actin–positive (α-SMA–positive) fibroblasts. Following CFIm25 knockdown in healthy human lung fibroblasts, we identified 808 genes with shortened 3′-UTRs, including those involved in the TGF …
What problem does this paper attempt to address?